NEPHROS, INC. Proceeds from Issuance of Preferred Stock and Preference Stock
NEPHROS, INC. (NEPH) reported Proceeds from Issuance of Preferred Stock and Preference Stock of $3.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock · last filed 2020-02-27
- NEPHROS, INC. proceeds from issuance of preferred stock and preference stock for the quarter ending 2018-12-31 was $0.00.
- NEPHROS, INC. proceeds from issuance of preferred stock and preference stock for fiscal 2018 was $3.00M.
| Period end | Proceeds from Issuance of Preferred Stock and Preference Stock 3 month | Proceeds from Issuance of Preferred Stock and Preference Stock 9 month | Proceeds from Issuance of Preferred Stock and Preference Stock 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $3.00M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $3.00M 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |